Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis

  title={Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis},
  author={Luiza Szarpak and Krzysztof Jerzy Filipiak and Aleksandra Gąsecka and Władysław B Gaweł and Dorota Kozieł and Miłosz Jarosław Jaguszewski and Jarosław Chmielewski and Anatolii Gozhenko and Karol Bielski and Paweł Wroblewski and Ivan Volodymyrovych Savytskyi and Lukasz Szarpak and Zubaid Rafique},
  journal={Cardiology Journal},
  pages={188 - 196}
Background Vitamin D is a likely candidate for treatment as its immune modulating characteristics have effects on coronavirus disease 2019 (COVID-19) patients. It was sought herein, to summarize the studies published to date regarding the vitamin D supplementation to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive patients. Methods A systematic review and meta-analysis were performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA… 

Tables from this paper


Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection
Serum 25OHD levels are lower in hospitalized COVID-19 patients than in population-based controls and these patients had a higher prevalence of deficiency, and any relationship between vitamin D concentrations or vitamin deficiency and the severity of the disease was not found.
A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19.
Low serum vitamin D levels are statistically significantly associated with the risk of COVID-19 infection and Supplementation of vitamin D especially in the deficiency risk groups is indicated.
Vitamin D and survival in COVID-19 patients: A quasi-experimental study
The effects of vitamin D on acute viral respiratory infections: A rapid review
Is remdesivir important in clinical practice as a treatment of COVID-19 ?
The present meta -analysis concluded that among patients with moderate COVID -19, those randomized to a 10 -day course of remdesivir did not have a statistically significant difference in clinical status compared with standard care at 11 days after initiation of treatment, but the difference was of uncertain clinical importance.
Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study
Regular bolus vitamin D supplementation taken either regularly over the preceding year or after the diagnosis of COVID-19 was effective in improving survival among hospitalized frail elderly CO VID-19 patients.
Vitamin D: A magic bullet or a myth?
Systematic review on current antiviral therapy in COVID-19 pandemic.
In the present pandemic and any future epidemics, all the related authorities should pursue many more RCTs, cohort and case series for a prospective outcome in the management and treatment guidelines.